ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2548

M-CSF-R Is a Critical Determinant for the Differentiation of Classical to Non-Classical Monocytes

Philip J. Homan1, Alexander Misharin1, Carla Cuda2, Salina Dominguez2, Rana Saber2, Fu-Nien Tsai3 and Harris R. Perlman4, 1Medicine-Rheumatology, Northwestern University, Chicago, IL, 2Northwestern University, Chicago, IL, 3Medicine, Rhuematology, Northwestern University, Chicago, IL, 4Feinberg School of Medicine, Northwestern University, Chicago, IL

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Auto-immunity, Macrophage, monocytes and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Rheumatoid Arthritis - Animal Models Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Colony-stimulating factors (CSF) are simply defined as haemotopoitec growth factors. However, CSFs have been implicated to have additional functions in various autoimmune diseases. Specifically M-CSF has been shown to effect the progression of CIA, a murine model of RA. Additional studies have also shown that M-CSF is required to maintain the monocyte derived macrophage population in the ankle. However, all of these studies utilized M-CSF or MCSFR knockout or mutant mice.  Here we generated MCSFR conditional mice that lack the receptor in myeloid cells. We hypothesize that M-CSF is integral to the development of monocytes and subsequent macrophage differentiation, and will affect the development of other autoimmune diseases.

Methods:

We generated mice lacking M-CSF-R specifically in myeloid cells (M-CSF-Rfl/flCreLysM) and assessed mice at 4 months of age for characterization of RA-like disease.  Monocyte turnover/proliferation and differentiation were examined in vivousing flow cytometric analyses.

Results:

M-CSF-Rfl/flCreLysM displayed a normal response and recovery to RA in our K/BxN serum transfer arthritis (STIA) model. However flow cytometry analysis revealed differential cell populations in multiple tissues within M-CSF-Rfl/flCreLysM mice compared to M-CSF-Rfl/fl mice. We observed a marked decreased in the non-classical monocytes in which the M-CSF-Rfl/fl was deleted.  Since blood monocytes are directly linked to the formation of tissue inflammatory macrophages we also examined synovial macrophages in the ankle.  We previously characterized synovial macrophages as MHCII–, tissue resident macrophages, and MHCII+ macrophages. M-CSF-Rfl/flCreLysM mice showed a significant decrease in MHCII+macrophages.

Conclusion:

M-CSF plays a central role in both monocyte differentiation in the blood and MHCII+ macrophage proliferation in the ankle. The lack of M-CSF-R depletion in both intermediate and non-classical monocytes, in the blood, suggests that expression of M-CSF-R is required for classical monocytes to differentiate into non-classical monocytes. This data also suggest that M-CSF can act as either an active or passive participant in the replenishment of synovial macrophages. M-CSF could be directly required for the differentiation of monocytes into synovial macrophages. The decrease in MHCII+ cells could also be due to the decreased ability of classical monocytes to differentiate into non-classical monocytes, suggesting that non-classical monocytes directly replenish the synovial macrophage populations. The M-CSF-Rfl/flCreLysM provides an important model to study autoimmune disease and identify the specific role of M-CSF in classical and non-classical monocyte differentiation and their ability to replenish both tissue resident and bone marrow derived macrophages during the progression of disease.


Disclosure: P. J. Homan, None; A. Misharin, None; C. Cuda, None; S. Dominguez, None; R. Saber, None; F. N. Tsai, None; H. R. Perlman, None.

To cite this abstract in AMA style:

Homan PJ, Misharin A, Cuda C, Dominguez S, Saber R, Tsai FN, Perlman HR. M-CSF-R Is a Critical Determinant for the Differentiation of Classical to Non-Classical Monocytes [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/m-csf-r-is-a-critical-determinant-for-the-differentiation-of-classical-to-non-classical-monocytes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/m-csf-r-is-a-critical-determinant-for-the-differentiation-of-classical-to-non-classical-monocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology